Intermittent Levosimendan Administration for Advanced Heart Failure Treatment in Adults with Congenital Heart Disease (Levo-ACHD Study)

<b>Background and Objective:</b> Heart failure (HF) is a major cause of morbidity in adults with congenital heart disease (ACHD), who may also have limited access to transplant. Intermittent levosimendan administration has shown benefit in advanced HF due to acquired heart disease, but currently, th...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Flavia Fusco, Ippolita Altobelli, Vito Casale, Nunzia Borrelli, Giovanni Domenico Ciriello, Rosaria Barracano, Assunta Merola, Nicola Grimaldi, Michela Palma, Giovanni Papaccioli, Anna Correra, Diego Colonna, Giancarlo Scognamiglio, Berardo Sarubbi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2026-06-01
coleção:	Medicina
Assuntos:	heart failure congenital heart disease ACHD levosimendan inotropes
Acesso em linha:	https://www.mdpi.com/1648-9144/62/6/1170
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!